STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Shares Sold by Nantahala Capital Management LLC

Nantahala Capital Management LLC trimmed its position in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) by 90.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 303,917 shares of the medical device company’s stock after selling 2,785,904 shares during the period. Nantahala Capital Management LLC owned about 8.67% of STRATA Skin Sciences worth $933,000 at the end of the most recent reporting period.

Separately, Azzad Asset Management Inc. ADV lifted its position in STRATA Skin Sciences by 289.5% during the first quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock worth $25,000 after buying an additional 49,800 shares during the period. Institutional investors own 32.43% of the company’s stock.

Insider Activity at STRATA Skin Sciences

In related news, CEO Dolev Rafaeli bought 19,100 shares of the stock in a transaction dated Monday, July 15th. The stock was acquired at an average price of $3.14 per share, for a total transaction of $59,974.00. Following the completion of the purchase, the chief executive officer now owns 143,156 shares in the company, valued at $449,509.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other STRATA Skin Sciences news, CEO Dolev Rafaeli bought 19,100 shares of the stock in a transaction dated Monday, July 15th. The stock was bought at an average cost of $3.14 per share, for a total transaction of $59,974.00. Following the completion of the purchase, the chief executive officer now directly owns 143,156 shares of the company’s stock, valued at $449,509.84. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Uri Geiger bought 230,573 shares of the company’s stock in a transaction dated Monday, July 15th. The shares were acquired at an average cost of $3.14 per share, for a total transaction of $723,999.22. Following the completion of the transaction, the director now owns 1,441,835 shares of the company’s stock, valued at approximately $4,527,361.90. The disclosure for this purchase can be found here. 40.43% of the stock is owned by insiders.

STRATA Skin Sciences Price Performance

SSKN opened at $2.75 on Tuesday. The stock has a market capitalization of $9.64 million, a PE ratio of -0.83 and a beta of 1.37. The company’s 50 day simple moving average is $3.12 and its 200 day simple moving average is $3.66. STRATA Skin Sciences, Inc. has a 1 year low of $2.51 and a 1 year high of $7.10. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.92 and a current ratio of 1.14.

STRATA Skin Sciences (NASDAQ:SSKN) last issued its earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter. STRATA Skin Sciences had a negative return on equity of 50.45% and a negative net margin of 25.40%. The firm had revenue of $8.44 million for the quarter. As a group, sell-side analysts expect that STRATA Skin Sciences, Inc. will post -1 EPS for the current year.

STRATA Skin Sciences Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.